Clinical Trial Update: A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating GW572016 with gemcitabine and oxaliplatin in metastatic pancreaticobiliary cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GW572016 (lapatinib)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Brown University | Conditions: Metastatic Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2014-05-05